Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (1)
Journals and Conferences
Denosumab, a fully human monoclonal antibody, has been approved for the treatment of postmenopausal osteoporosis. The therapeutic effect of denosumab rests on its ability to inhibit osteoclast… (More)